{"nct_id":"NCT02783300","title":"An Open-label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK3326595 in Participants With Solid Tumors and Non-Hodgkin's Lymphoma","status":"COMPLETED","status_verified_date":"2025-02","start_date":"2016-08-30","start_date_type":"ACTUAL","primary_completion_date":"2023-08-30","primary_completion_date_type":"ACTUAL","completion_date":"2023-08-30","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}